## Understanding Positive Predictive Value (PPV) **Key Point:** PPV is the probability that a person with a positive test result actually has the disease. It is heavily influenced by disease prevalence, not just test sensitivity and specificity. ### Formula for PPV $$PPV = \frac{TP}{TP + FP} = \frac{\text{Sensitivity} \times \text{Prevalence}}{\text{Sensitivity} \times \text{Prevalence} + (1 - \text{Specificity}) \times (1 - \text{Prevalence})}$$ ### Calculation in This Scenario Given: - Sensitivity = 85% - Specificity = 90% - Prevalence = 5% (0.05) $$PPV = \frac{0.85 \times 0.05}{(0.85 \times 0.05) + (0.10 \times 0.95)} = \frac{0.0425}{0.0425 + 0.095} = \frac{0.0425}{0.1375} ≈ 31\%$$ **High-Yield:** Despite 90% specificity (excellent), the PPV is only ~31% because the disease prevalence is only 5%. In a low-prevalence population, most positive tests are false positives. ### Why PPV Drops with Low Prevalence | Prevalence | PPV (with 85% Sens, 90% Spec) | |---|---| | 1% | ~8% | | 5% | ~31% | | 10% | ~49% | | 50% | ~89% | **Clinical Pearl:** This is why screening tests perform poorly in low-prevalence populations. GDM prevalence in India is ~5–10%, so a positive screening test requires confirmation with a diagnostic test (75-g OGTT). **Mnemonic:** **PPVP** — Positive Predictive Value depends on Prevalence. High prevalence → high PPV; low prevalence → low PPV, regardless of test quality. ### Why the Other Options Are Misleading - **Option 1 (correct):** Low prevalence is the PRIMARY driver of low PPV in this scenario. - **Option 2:** The false-positive rate (1 − specificity = 10%) is actually low; the issue is that false positives outnumber true positives because disease is rare. - **Option 3:** Sensitivity is adequate (85%); the problem is not sensitivity but prevalence. - **Option 4:** Confounding variables would affect test validity, not the mathematical relationship between prevalence and PPV.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.